The Association of Pharmaceutical Medicine Singapore (APMS) is a not-for-profit organisation established in 2006, run by and for physicians and scientists in pharmaceutical companies and allied organisations in Singapore. Affiliated to the Federation of Associations of Pharmaceutical Physicians & Pharmaceutical Medicine (www.ifapp.org), the purpose of the APMS is to enhance the knowledge, expertise, and skills of physicians and scientists in our organisations thereby enabling us to better support the availability and appropriate use of pharmaceutical medicines for the benefit of patients and society as a whole. Our online discussion platforms, educational events, and networking sessions help our members to actively engage with each other to exchange ideas and knowledge around areas of mutual interest. We foster open discussion and debate around all relevant topics. The APMS engenders a spirit of partnership and mutual understanding between all professionals working in the field of pharmaceutical medicine: professionals working in pharmaceutical companies and allied organisations, academia, regulatory bodies, authorities and policy makers. Our overarching aim is to support the healthcare community in Singapore and other countries in the region to improve the lives of their patients.


The Association of Pharmaceutical Medicine Singapore, Level 30, Singapore Land Tower, 50 Raffles Place, Singapore, 048623


The APMS members present at the General Assembly have all agreed to clarify the APMS membership criteria as following:

  • Medical doctors working in healthcare industry
  • OR those with Life Science Degrees (BSc+) working in Medical Affairs (including pharmacovigilance, regulatory, clinical operations, etc...) in pharmaceutical and medical device companies
  • AND currently residing or employed in Singapore


suhail ali - Treasurer

A Clinical Research Professional with more than 17 years of global experience in Clinical Development and Project Management. Currently leading a team of Project Directors, Managers and Specialists in Asia Pacific for Syneos Health, Oncology. During his career Suhail has worked for Global Pharma, Biotech and CRO companies gaining insight into clinical development, resource optimization and outsourcing models. He has acquired a wealth of project management experience in various phases of clinical research from phase I to IV while leading many Oncology Clinical Development Programmes and he has played an important role in bringing novel drugs and vaccines to market. Prior to entering clinical research, Suhail completed postgraduate training in Pharmacy. He is a registered pharmacist with the Delhi Pharmacy Council, a life member of the Indian Pharmaceutical Association and a member of the Project Management Institute, USA and Singapore chapters.

ARTI DHAR - General Secretary

Dr Arti Dhar is a Medical Professional with over 15 years of experience in the healthcare industry spanning across Medical practice, Health care communication, Scientific communication and Medical affairs. She is a founding member of APMS and very passionate about accomplishing the vision of driving excellence in Medical Affairs in the region. Arti has worked in different geographies including India, South Africa and Singapore.

aileen dualan - past president

Dr Aileen Dualan has been Asia Pacific Regional Global Medical Affairs Lead at MSD International GmBH since November 2016. She began her industry career in pharmacovigilance, followed by medical affairs in the Philippines, before moving to Singapore in 2010. She has led various regional medical affairs functions, first at Abbott, then Novartis, and now MSD. Aileen received her medical degree from the University of the Philippines in 1992. She was board-certified by the American Board of Pediatrics in 1997 and has advanced training in infectious diseases, microbiology, and public health. She attended the University of Maryland in Baltimore for Epidemiology. Her master’s thesis was on the molecular immune determinants of malaria susceptibility, and her doctoral dissertation was on the molecular epidemiology of imipenem resistant Pseudomonas aeruginosa. She spent 10 years in an academic setting in Chicago, Illinois and Baltimore, Maryland in the US and in the Philippines, prior to working in the pharmaceutical industry.

ALAN MCDOUGALL - Vice president

Dr Alan McDougall qualified in medicine in 1984 from the University of Glasgow. He trained as a family doctor and worked near Glasgow. His interest in diabetes led to him joining Novo Nordisk in 1998, becoming their UK Medical Director in 2001. Alan gained membership of the UK’s Faculty of Pharmaceutical Medicine in 2002 and became a Fellow in 2013. Alan joined Astellas UK as Medical Director in 2009. He moved to a regional European role in 2014 and was promoted to Head of Medical Affairs for Asia Oceania in 2016. His interests include leadership and team development.

AJAY TIKU - president

Dr Ajay Tiku completed his MBChB training in Zambia and M.Med Internal Medicine in South Africa. An executive management-training program from Vanderbilt University, USA, and an Executive Leadership Program from IMD University, Switzerland has added to his exceptional leadership style. Following eight years of clinical practice in Africa, Dr Tiku went on to gain vast experience in the field of medical affairs, and scientific research & development. He has worked for just about two decades, with Global research based pharmaceutical organisations. Dr Tiku has published in the area of Diabetes and has been a guest speaker at healthcare related meetings in various countries. He has gained work experience within the USA, Africa and Asia in various senior positions of responsibility. He is currently living and working in a leadership role within the Pharmaceutical industry, based in Singapore, along with his wife and two children.